A NEW PARADIGM FOR TREATMENT
ELIVE™ – Endogenous Laser Induced Ventricular Enhancement.
ELIVE Medical is developing an innovative CO2 hollow fiber waveguide with high flexibility, suitable for incorporation into catheters. This technology, for the first time, enables a CO2 laser to be used in a trans-catheter setting.
ELIVE™ therapy targets an unmet clinical need and, once fully developed and tested, is expected to create a valid therapeutic option to those heart failure patients who would not otherwise have a therapeutic alternative.
COMPANYThe founders of ELIVE Medical include Prof. Dr. med. Hans-Michael Klein, M.D., a renowned, widely published German cardiac surgeon who has performed thousands of surgical procedures and who has traveled and lectured extensively on five continents. Dr. Klein is an acknowledged leader in the international cardiac surgery community based on his 30+ years of clinical research and surgical experience.
The second founder is Dr. Michael Heke, Ph.D., who has specialized in stem cell research since 2001. His initial interest was to identify the molecular basis of human embryonic stem cells, and to elucidate the genetic route taken as they develop into an organism. Later, he shifted his attention towards clinical stem cell applications in order to tap the potential of stem cell research for translational medicine. Jointly with Prof. Klein he established a paradigm-shifting, laser-induced, stem cell therapy for patients suffering from heart failure.
The third founder was Vince Puglisi, an executive with over 25 years experience in the successful sale and marketing of cardiac related medical devices. As part of his wide ranging international business development experience, Vince worked closely with Professor Klein and many other cardiac surgeons and cardiologists as well as with a wide network of cardiac care distributors. Vince sadly passed away in 2015, but the company still benefits from his groundwork and international distributor network.